P

Inventor

MEISENHEIMER PONCHO

US50 patents
⚠️ This page may combine multiple inventors who share the name “MEISENHEIMER PONCHO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PROMEGA CORP

43 patents
US9797889B2Oct 24, 2017

Activation of bioluminescence by structural complementation

PROMEGA CORP33 citations97
US9797890B2Oct 24, 2017

Activation of bioluminescence by structural complementation

PROMEGA CORP24 citations97
US10288605B2May 14, 2019

Activation of bioluminescence by structural complementation

PROMEGA CORP10 citations92
US10107800B2Oct 23, 2018

Activation of bioluminescence by structural complementation

PROMEGA CORP14 citations92
US9938564B2Apr 10, 2018

Substituted imidazo[1,2-a]pyrazines for use in bioluminogenic methods

PROMEGA CORP7 citations92
US9869670B2Jan 16, 2018

Activation of bioluminescence by structural complementation

PROMEGA CORP12 citations92
US7951550B2May 31, 2011

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

PROMEGA CORP27 citations92
US10815247B2Oct 27, 2020

Functionalized NANOLUC inhibitors

PROMEGA CORP11 citations85
US11661623B2May 30, 2023

Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use

PROMEGA CORP3 citations84
US9139868B2Sep 22, 2015

Silicon and germanium dyes for use in genetic identity

PROMEGA CORP7 citations84
US9139836B2Sep 22, 2015

Imidazo[1,2-a]pyrazine derivatives

PROMEGA CORP5 citations84
US11524946B2Dec 13, 2022

Polymerase inhibitors and related compositions and methods

PROMEGA CORP4 citations83
US11493504B2Nov 8, 2022

Activation of bioluminescene by structural complementation

PROMEGA CORP4 citations83
US10648971B2May 12, 2020

Activation of bioluminescence by structural complementation

PROMEGA CORP6 citations83
US10184936B2Jan 22, 2019

Activation of bioluminescence by structural complementation

PROMEGA CORP5 citations83
US10077244B2Sep 18, 2018

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

PROMEGA CORP5 citations83
US9551705B2Jan 24, 2017

Compositions and methods for capture of cellular targets of bioactive agents

PROMEGA CORP6 citations83
US9689868B2Jun 27, 2017

Protein labeling with cyanobenzothiazole conjugates

PROMEGA CORP7 citations81
US10316070B2Jun 11, 2019

Dual protected pro-coelenterazine substrates

PROMEGA CORP3 citations73
US11939310B2Mar 26, 2024

Polymerase inhibitors and related compositions and methods

PROMEGA CORP2 citations72
US11072812B2Jul 27, 2021

Substrates for covalent tethering of proteins to functional groups or solid surfaces

PROMEGA CORP3 citations72
US10168323B2Jan 1, 2019

Compositions and methods for capture of cellular targets of bioactive agents

PROMEGA CORP5 citations72
US10400264B2Sep 3, 2019

5,5-disubstituted luciferins and their use in luciferase-based assays

PROMEGA CORP4 citations71
US11442063B2Sep 13, 2022

Broad spectrum kinase binding agents

PROMEGA CORP1 citations69
US9790537B2Oct 17, 2017

Quinone-masked probes as labeling reagents for cell uptake measurements

PROMEGA CORP5 citations68
US12366572B2Jul 22, 2025

Activation of bioluminescence by structural complementation

PROMEGA CORP0 citations62
US12367513B2Jul 22, 2025

Activation of bioluminescence by structural complementation

PROMEGA CORP0 citations62
US11261478B2Mar 1, 2022

Thermal stable luciferase with improved resistance to inhibition by luciferin break-down products

PROMEGA CORP0 citations62
US11192894B2Dec 7, 2021

Cell impermeable coelenterazine analogues

PROMEGA CORP0 citations62
US11072811B2Jul 27, 2021

Substrates for covalent tethering of proteins to functional groups or solid surfaces

PROMEGA CORP0 citations62
US10577370B2Mar 3, 2020

Cell impermeable coelenterazine analogues

PROMEGA CORP1 citations62
US12291511B2May 6, 2025

Polymerase inhibitors and related compositions and methods

PROMEGA CORP0 citations61
US12221648B2Feb 11, 2025

Substrates for covalent tethering of proteins to functional groups or solid surfaces

PROMEGA CORP0 citations61
US10976312B2Apr 13, 2021

Compositions and methods for capture of cellular targets of bioactive agents

PROMEGA CORP0 citations61
US10913972B2Feb 9, 2021

5,5-disubstituted luciferins and their use in luciferase-based assays

PROMEGA CORP0 citations60
US9932365B2Apr 3, 2018

Protein labeling with cyanobenzothiazole conjugates

PROMEGA CORP1 citations60
US12078634B2Sep 3, 2024

Broad spectrum kinase binding agents

PROMEGA CORP0 citations59
US12571031B2Mar 10, 2026

Nucleic acid modifying reagents and uses thereof

PROMEGA CORP0 citations57
US11136615B2Oct 5, 2021

Compositions and methods for stabilizing benzothiazole luciferin analogs

PROMEGA CORP0 citations51
US10745365B2Aug 18, 2020

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

PROMEGA CORP0 citations51
US10590162B2Mar 17, 2020

Reversible metal ion chelators

PROMEGA CORP0 citations42
US12227781B2Feb 18, 2025

Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles

PROMEGA CORP0 citations40
US10836767B2Nov 17, 2020

Serum stable pro-coelenterazine analogues

PROMEGA CORP0 citations40

KLAUBERT DIETER H

2 patents

ANDERSON JESSICA

2 patents

CALI JAMES J

1 patent

KELTS JESSICA

1 patent

CORONA CESEAR

1 patent